Cargando…
CIAPIN1 and ABCA13 are markers of poor survival in metastatic ovarian serous carcinoma
BACKGROUND: The objective of this study was to investigate the expression and clinical role of 14 genes previously shown to be associated with chemotherapy response and/or progression-free survival in a smaller series of ovarian serous carcinoma effusions. METHODS: Advanced-stage serous ovarian carc...
Autores principales: | Nymoen, Dag Andre, Holth, Arild, Hetland Falkenthal, Thea E, Tropé, Claes G, Davidson, Ben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336750/ https://www.ncbi.nlm.nih.gov/pubmed/25889687 http://dx.doi.org/10.1186/s12943-015-0317-1 |
Ejemplares similares
-
Claudin-10 is a new candidate prognostic marker in metastatic high-grade serous carcinoma
por: Davidson, Ben, et al.
Publicado: (2023) -
Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma
por: Davidson, Ben, et al.
Publicado: (2020) -
Death domain-associated protein (DAXX) expression is associated with poor survival in metastatic high-grade serous carcinoma
por: Davidson, Ben, et al.
Publicado: (2020) -
CIAPIN1 nuclear accumulation predicts poor clinical outcome in epithelial ovarian cancer
por: Cai, Xiaolan, et al.
Publicado: (2012) -
Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions
por: Davidson, Ben, et al.
Publicado: (2011)